BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31362879)

  • 21. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison.
    Giannini C; De Carlo M; Tamburino C; Ettori F; Latib AM; Bedogni F; Bruschi G; Presbitero P; Poli A; Fabbiocchi F; Violini R; Trani C; Giudice P; Barbanti M; Adamo M; Colombo P; Benincasa S; Agnifili M; Petronio AS
    Int J Cardiol; 2017 Sep; 243():126-131. PubMed ID: 28595747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation.
    Giordano A; Corcione N; Ferraro P; Pieri P; Avellino R; Frati G; De Persio G; Altamura L; Tomai F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2019 May; 20(5):351-357. PubMed ID: 30676494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valve-in-valve transcatheter aortic valve implantation with CoreValve/Evolut R
    Scholtz S; Piper C; Horstkotte D; Gummert J; Ensminger SM; Börgermann J; Scholtz W
    J Interv Cardiol; 2018 Jun; 31(3):384-390. PubMed ID: 29490430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
    Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
    Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve.
    Simonato M; Webb J; Kornowski R; Vahanian A; Frerker C; Nissen H; Bleiziffer S; Duncan A; Rodés-Cabau J; Attizzani GF; Horlick E; Latib A; Bekeredjian R; Barbanti M; Lefevre T; Cerillo A; Hernández JM; Bruschi G; Spargias K; Iadanza A; Brecker S; Palma JH; Finkelstein A; Abdel-Wahab M; Lemos P; Petronio AS; Champagnac D; Sinning JM; Salizzoni S; Napodano M; Fiorina C; Marzocchi A; Leon M; Dvir D
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27301396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R.
    Hellhammer K; Piayda K; Afzal S; Kleinebrecht L; Makosch M; Hennig I; Quast C; Jung C; Polzin A; Westenfeld R; Kelm M; Zeus T; Veulemans V
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2314-2322. PubMed ID: 30466830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.
    Harrison JK; Hughes GC; Reardon MJ; Stoler R; Grayburn P; Hebeler R; Liu D; Chang Y; Popma JJ;
    JACC Cardiovasc Interv; 2017 Jan; 10(2):168-175. PubMed ID: 28104211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm.
    Eitan A; Witt J; Stripling J; Haselbach T; Rieß FC; Schofer J
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1374-1379. PubMed ID: 29521464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry.
    Regazzoli D; Chiarito M; Cannata F; Pagnesi M; Miura M; Ziviello F; Picci A; Reifart J; De Marco F; Bedogni F; Adamo M; Curello S; Teles R; Taramasso M; Barbanti M; Tamburino C; Stefanini GG; Mangieri A; Giannini F; Pagnotta PA; Maisano F; Kim WK; Van Mieghem NM; Colombo A; Reimers B; Latib A;
    JACC Cardiovasc Interv; 2020 Jan; 13(2):196-206. PubMed ID: 31883714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve.
    Attizzani GF; Dallan LAP; Markowitz A; Yakubov SJ; Deeb GM; Reardon MJ; Forrest JK; Mangi AA; Huang J; Popma JJ
    JACC Cardiovasc Interv; 2020 Aug; 13(15):1816-1824. PubMed ID: 32763073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience of a self-expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.
    Dowling C; Firoozi S; Panoulas V; Dalby M; Kashyap MN; Kabir T; Kalogeras K; Buch MH; Levy R; Chowdhary S; Saraf S; Roberts D; More R; Wiper A; Abdelaziz HK; Neylon A; Mylotte D; Pisaniello AD; Fraser DGW; Anderson R; Cunnington MS; Malkin CJ; Blackman DJ; Brennan PF; Owens CG; Manoharan G; Spence MS; Brecker SJ
    Catheter Cardiovasc Interv; 2020 Jun; 95(7):1340-1346. PubMed ID: 31713325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
    Ojeda S; Hidalgo F; Romero M; Mazuelos F; Suárez de Lezo J; Martín E; Lostalo A; Luque A; González R; Fernández A; López-Aguilera J; Segura J; Guerrero N; Pan M
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):783-790. PubMed ID: 31062927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform in a Real-World Registry.
    Dallan LAP; Tang G; Forrest JK; Reardon MJ; Szeto WY; Kodali SK; Baeza C; Eisenberg R; Attizzani GF
    Circ Cardiovasc Interv; 2023 Mar; 16(3):e012623. PubMed ID: 36943929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
    Bhogal S; Rogers T; Merdler I; Reddy P; Ali S; Shea C; Zhang C; Ben-Dor I; Satler LF; Waksman R
    Int J Cardiol; 2023 Oct; 389():131196. PubMed ID: 37479148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
    Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
    PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID).
    Alnasser S; Cheema AN; Simonato M; Barbanti M; Edwards J; Kornowski R; Horlick E; Wijeysundera HC; Testa L; Bedogni F; Amrane H; Walther T; Pelletier M; Latib A; Laborde JC; Hildick-Smith D; Kim WK; Tchetche D; Agrifoglio M; Sinning JM; van Boven AJ; Kefer J; Frerker C; van Mieghem NM; Linke A; Worthley S; Asgar A; Sgroi C; Aziz M; Danenberg HD; Labinaz M; Manoharan G; Cheung A; Webb JG; Dvir D;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28400461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter aortic valve implantation with the 34 mm self-expanding CoreValve Evolut R: initial experience in 101 patients from a multicentre registry.
    Kuhn C; Frerker C; Meyer AK; Kurz T; Schäfer U; Deuschl F; Abdel-Wahab M; Schewel D; Elghalban A; Kuck KH; Frey N; Frank D
    EuroIntervention; 2018 Jun; 14(3):e301-e305. PubMed ID: 29808820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.
    Dowling C; Firoozi S; Doyle N; Blackman DJ; Malkin CJ; Cunnington MS; Saraf S; Buch MH; Levy R; Chowdhary S; Spence MS; Manoharan G; Owens CG; Brennan PF; Roberts D; More R; Wiper A; Abdelaziz HK; Mylotte D; Neylon A; Martin N; Mercanti F; Dorman S; Panoulas V; Dalby M; Kashyap MN; Kabir T; Kovac J; Kontoprias K; Malik IS; Ghada MW; Sen S; Ruparelia N; Demir OM; Frame A; Uren NG; Anderson R; Rajathurai T; Tapp L; Deegan L; Grech E; Hall I; Neville M; Rampat R; Hildick-Smith D; Mullen M; Kennon S; Chandrala P; Doshi S; Brecker SJ
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):751-757. PubMed ID: 30394657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of Concomitant Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement for Degenerated Surgical Aortic Bioprosthesis: Insights From the PARTNER 2 Aortic Valve-in-Valve Registry.
    Sathananthan J; Murdoch DJ; Lindman BR; Zajarias A; Jaber WA; Cremer P; Wood D; Moss R; Cheung A; Ye J; Hahn RT; Crowley A; Leon MB; Mack MJ; Webb JG
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1154-1160. PubMed ID: 29929637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.